NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-128 Cr | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr | ₹11 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-128 Cr |
| Mar2024 | ₹-205 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-119 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-128 Cr | Negative | |
| Mar2024 | ₹-205 Cr | Negative | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-119 Cr | Negative | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹203.6 Cr | -3% | -9% | -42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -3% |
-9% |
-42.3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses